Melinda Amelia Anamdi, PA-C

Melinda Anamdi practices at ENT and Allergy Associates of Florida in Tampa, Florida.

Melinda Anamdi's NPI, 1710122817, was assigned on December 4, 2008. Melinda Anamdi holds Florida license PA9117549.

Melinda Anamdi's primary practice is ENT and Allergy Associates of Florida, at 5105 N Armenia Ave, Tampa, FL 33603 in Hillsborough County. The practice phone is (561) 338-3267.

Melinda Anamdi's primary practice is ENT and Allergy Associates of Florida in Tampa, Florida. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Melinda Anamdi to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Melinda Anamdi practices. Vendor and product names are available with a free account.

Physician assistant is Melinda Anamdi's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Melinda Anamdi is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Melinda Anamdi's licenses on file in 2 states: Florida and New York.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, contact dermatitis, hives and itchy rashes among the conditions Melinda Anamdi treats.

CMS data shows 117 Medicare services from Melinda Anamdi across 6 procedure codes in 2024, for 74 Medicare patients. Medicare paid $9,209 for them. Every service was in an office.

CMS counts 74 Medicare patients who saw Melinda Anamdi in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Melinda Anamdi's median patient age at 53, with 52% women.

In 2024, Melinda Anamdi wrote 220 Medicare Part D claims for 99 patients. 88% of them were for generic drugs. CMS names the drug for 118 of them, across 4 drugs with 11 or more claims each, at $1,674 in total drug cost.

Melinda Anamdi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 56 general payments to Melinda Anamdi from 13 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 96% of the total. GlaxoSmithKline, LLC. paid the most, $422.